Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

BioCentury

May 15, 2020

Repurposed autoimmune therapies head for controlled COVID-19 studies in Europe

Boursier.com

May 14, 2020

Clôture Paris : le CAC40 poursuit sa correction mais limite la casse

BFM Bourse -TradingSat

May 14, 2020

ABIVAX : LA BIOTECH ABIVAX REBONDIT DANS LA PERSPECTIVE D’UN VASTE ESSAI CLINIQUE CONTRE LE COVID-19

Option Finance

May 14, 2020

ABIVAX bien positionné contre le Covid-19

L'Usine Nouvelle

May 14, 2020

Abivax teste un traitement complet et prometteur contre le Covid-19

  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn